VM
ADVM

VHCP Management’s Adverum Biotechnologies ADVM Stock Holding History

VHCP Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.2M Hold
110,274
– – 3.44% 7
2016
Q3 		$4.53M Hold
110,274
– – 4.46% 5
2016
Q2 		$3.48M Hold
110,274
– – 3.61% 6
2016
Q1 		$5.7M Hold
110,274
– – 4.95% 6
2015
Q4 		$10.5M Sell
110,274
-28,000
-20% -$2.46M 6.35% 7
2015
Q3 		$11.4M Hold
138,274
– – 2.92% 11
2015
Q2 		$22.5M Hold
138,274
– – 6.33% 6
2015
Q1 		$56M Hold
138,274
– – 12.9% 3
2014
Q4 		$73.1M Hold
138,274
– – 20.1% 2
2014
Q3 		$42.8M Buy
+138,274
New +$41.1M 19.25% 1

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VHCP Management's ADVM Position: Q4 2016 in Review

VHCP Management held its Adverum Biotechnologies (ADVM) position steady in Q4 2016 at 110,274 shares worth $3.2M. The position accounts for 3.44% of the portfolio, ranked #7.

VHCP Management first reported a position in ADVM in Q3 2014 and has held it in 10 quarters since. The position peaked at $73.1M in Q4 2014. 83 funds tracked by Wall St. Rank hold ADVM as of Q4 2016.

  • VHCP Management held 110,274 shares of Adverum Biotechnologies worth $3.2M as of Q4 2016.
  • VHCP Management left its Adverum Biotechnologies share count unchanged in Q4 2016.
  • Adverum Biotechnologies made up 3.44% of VHCP Management's portfolio in Q4 2016, its #7 holding.
  • VHCP Management first reported a position in Adverum Biotechnologies in Q3 2014 and has held it in 10 quarters since.
  • VHCP Management's Adverum Biotechnologies position peaked at $73.1M in Q4 2014.
  • 83 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.